Trial Profile
Study of inactivated, split-virion influenza vaccine compared with standard Fluzone vaccine in infants and children.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Sanofi
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 May 2008 The expected completion date for this trial is now 1 Sep 2008.
- 21 Dec 2006 Status change